Clinical trial
Normalizing Platelet Reactivity After Treatment With Ticagrelor
NCT02201394 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Normalizing Platelet Reactivity After Treatment With Ticagrelor
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- June 30, 2016
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.